Skip to main content

Advertisement

SpringerLink
Log in

Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”

  • Letter to the Editor
  • Published:
Osteoporosis International Aims and scope Submit manuscript

A Correction to this article was published on 11 March 2022

A Letter to the Editor to this article was published on 17 February 2022

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Change history

References

  1. Ha J, Jeong C, Han KD, Lim Y, Kim MK, Kwon HS, Song KH, Kang MI, Baek KH (2021) Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data. Osteoporos Int 32:2543–2553. https://doi.org/10.1007/s00198-021-06032-z

    Article  CAS  PubMed  Google Scholar 

  2. Parkkari J, Kannus P, Palvanen M, Natri A, Vainio J, Aho H, Vuori I, Järvinen M (1999) Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients. Calcif Tissue Int 65:183–187. https://doi.org/10.1007/s002239900679

    Article  CAS  PubMed  Google Scholar 

  3. Komorita Y, Ohkuma T, Iwase M et al (2021) Polypharmacy and bone fracture risk in patients with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetes Res Clin Pract 181:109097. https://doi.org/10.1016/j.diabres.2021.109097

    Article  PubMed  Google Scholar 

  4. Bourgeois FT, Shannon MW, Valim C, Mandl KD (2010) Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 19:901–910. https://doi.org/10.1002/pds.1984

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lipska KJ, Krumholz H, Soones T, Lee SJ (2016) Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 diabetes. JAMA 315:1034–1045. https://doi.org/10.1001/jama.2016.0299

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

    J. Ha

  2. Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

    K.-H. Baek

Authors
  1. J. Ha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K.-H. Baek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K.-H. Baek.

Ethics declarations

Conflicts of interest

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised: The author name J. Ha was incorrectly written as H. Jeonghoon, and K.-H. Baek was incorrectly written as B. Ki-Hyun.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ha, J., Baek, KH. Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”. Osteoporos Int 33, 955–956 (2022). https://doi.org/10.1007/s00198-022-06336-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-022-06336-8

Search

Navigation